The VADEX technology is a self-adjuvanting protein nanoparticle platform. The building block of VADEX technology is a fusion protein combining an amphipathic helical peptide (AHP) and a superfolder GFP (sfGFP). The precisely designed 19 a.a. AHP serves both as a polymerization module and an adjuvant. This fusion protein can be self-assembled into a thermally-stable protein nanoparticle (PNP) that endures ambient temperature storage up to 40 oC for two months. A target antigen can be expressed on the surface of nanoparticle by either loop insertion (VADEX-PEP) or strand complementation (VADEX-Pro) through sfGFP.  Being self-adjuvanting,  VADEX can truly enables Global Vaccination effort that protects every child from Sahara desert to Amazon rain forest. 

Here is a visitor survey to help us find out the best approach for you to join this endeavor!

Please enable JavaScript in your browser to complete this form.
Your preferences
Thanks for you time!